Proteinase-activated receptors

Pharmacological Reviews

Volumn 53, Issue 2, 2001, Pages 245-282

  Macfarlane, Scott R ^a   Seatter, Michael J ^a   Kanke, Toru ^a   Hunter, Gary D ^a   Plevin, Robin ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBIN RECEPTOR;

CHEMOTAXIS; ENDOCYTOSIS; GENETIC DISORDER; INFLAMMATION; MOLECULAR CLONING; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; THROMBOSIS;

ANIMALS; BONE AND BONES; CARDIOVASCULAR SYSTEM; HUMANS; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PLATELET AGGREGATION; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION;

EID: 0035019636     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (430)

1. Abraham LA, Chinni C, Jenkins AL, Lourbakos A, Ally N, Pike RN and Mackie EJ (2000) Expression of protease-activated receptor-2 by osteoblasts. Bone 26:7-14.
2. Abraham LA and Mackie EJ (1999) Modulation of osteoblast-like-cell behavior by activation of protease activated receptor-1. J Bone Miner Res 14:1320-1329.
3. Ahn HS, Arik L, Boykow G, Burnett DA, Caplen MA, Czarniecki M, Domalski MS, Foster C, Manna M, Stamford AW and Wu YS (1999) Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists. Bioorg Med Chem Lett 9:2073-2078.
4. Ahn HS, Foster C, Boykow G, Arik L, Smith-Torhan A, Hesk D and Chatterjee M (1997) Binding of a thrombin receptor tethered ligand analogue to human platelet thrombin receptor. Mol Pharmacol 51:350-356.
5. Ahn HS, Foster C, Boykow G, Stamford A, Manna M and Graziano M (2000) Inhibition of cellular action of thrombin by N3-cyclopropyl-7-([4-(1-methylethyl-)phenyl]methyl)-7H-pyrrolo[3,2-f] quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. Biochem Pharmacol 60:1425-1434.
6. Akers IA, Parsons M, Hill MR, Hollenberg MD, Sanjar S, Laurent GJ and McAnulty RJ (2000) Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am J Physiol-Lung Cell Mol Physiol 278:L193-L201.
7. Al-Ani B, Saifeddine M and Hollenberg MD (1995) Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle. Can J Physiol Pharmacol 73:1203-1207.
8. Al-Ani B, Saifeddine M, Kawabata A and Hollenberg MD (1999) Proteinase activated receptor 2: role of extracellular loop 2 for ligand-mediated activation. Br J Pharmacol 128:1105-1113.
9. Albrightson CR, Zabko-Potapovich B, Dytko G, Bryan WM, Hoyle K, Moore ML and Stadel JM (1994) Analogues of the thrombin receptor tethered-ligand enhance mesangial cell proliferation. Cell Signalling 6:743-750.
10. Alexopoulos K, Matsoukas J, Tselios T, Roumelioti P, Mavromoustakos T and Holada K (1998) A comparative SAR study of thrombin receptor derived non peptide mimetics: importance of phenyl/guanidino proximity for activity. Amino Acids 15:211-220.
11. Algermissen B, Sitzmann J, Nurnberg W, Laubscher JC, Henz BM and Bauer F (2000) Distribution and potential biologic function of the thrombin receptor PAR-1 on human keratinocytes. Arch Dermatol Res 292:488-495.
12. Aim AK, Gagnemo-Persson R, Sorsa T and Sundelin J (2000) Extrapancreatic trypsin-2 cleaves proteinase-activated receptor-2. Biochem Biophys Res Commun 275:77-83.
13. Andersen H, Greenberg DL, Fujikawa K, Xu WF, Chung DW and Davie EW (1999) Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci USA 96:11189-11193.
14. Andrade-Gordon P, Mayanoff BE, Derian CK, Zhang HC, Addo MF, Darrow AL, Eckardt AJ, Hoekstra WJ, McComsey DF, Oksenberg D, Reynolds EE, Santulli RJ, Scarborough RM, Smith CE and White KB (1999) Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor. Proc Natl Acad Sci USA 96:12257-12262.
15. 2+ in the vascular contraction caused by a thrombin receptor activating peptide. Eur J Pharmacol 256:37-44.
16. Antonaccio MJ, Normandin D, Serafino R and Moreland S (1993) Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth-muscle. J Pharmacol Exp Ther 286:125-132.
17. Apostolidis A and Weiss RH (1997) Divergence in the G-protein-coupled receptor mitogenic signalling pathway at the level of Raf kinase. Cell Signalling 9:439-445.
18. 12 requirement for thrombin-stimulated gene expression and DNA synthesis in 1321N1 astrocytoma cells. J Biol Chem 270:20073-20077.
19. Azim AC, Barkalow K, Chou J and Hartwig JH (2000) Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor. Blood 95:959-964
20. Babich M, King KL and Nissenson RA (1990) Thrombin stimulates inositol phosphate production and intracellular free calcium by a pertussis toxin-insensitive mechanism in osteosarcoma cells. Endocrinology 126:948-954.
21. Bachhuber BG, Sarembock IJ, Gimple LW and Owens GK (1997) Alpha-thrombin induces transforming growth factor-beta(1) mRNA and protein in cultured vascular smooth muscle cells via a proteolytically activated receptor. J Vascular Res 34:41-48.
22. Baffy G, Yang L, Raj S, Manning DR and Williamson JR (1994) G protein coupling to the thrombin receptor in Chinese hamster lung fibroblasts. J Biol Chem 269: 8483-8487.
23. Bahou WF and Demetrick DJ (1997) The human thrombin receptor gene and the 5q-syndrome. Leukemia & Lymphoma 27:1-10.
24. Bahou WF, Kutok JL, Wong A, Potter CL and Coller BS (1994) Identification of a novel thrombin receptor sequence required for activation-dependent responses. Blood 84:4195-4202.
25. Banga HS, Walker RK, Winberry LK and Rittenhouse SE (1988) Platelet adenylate cyclase and phospholipase C are affected differentially by ADP-ribosylation. Effects on thrombin-mediated responses. Biochem J 252:297-300.
26. 2+ channels of portal vein smooth muscle cells. Circ Res 72:1317-1325.
27. Bar-Shavit R, Kahn A, Fenton JWD and Wilner GD (1983) Receptor-mediated chemotactic response of a macrophage cell line (J774) to thrombin. Lab Invest 49:702-707.
28. Bartha K, Brisson C, Archipoff G, DeLasalle C, Lanza F, Cazenave JP and Beretz A (1993) Thrombin regulates tissue factor and thrombomodulin messenger-RNA levels and activities in human saphenous-vein endothelial-cells by distinct mechanisms. J Biol Chem 268:421-429.
29. Bartha K, Domotor E, Lanza F, Adam-Vizi V and Machovich R (2000) Identification of thrombin receptors in rat brain capillary endothelial cells. J Cereb Blood Flow Metab 20:175-182.
30. Beecher KL, Andersen TT, Fenton JW and Festoff BW (1994) Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J Neurosci Res 37:108-115.
31. Belham CL, Tate RJ, Scott PH, Pemberton AD, Miller HRP, Wadsworth RM, Gould GW and Plevin R (1996) Trypsin stimulates proteinase-activated receptor-2-dependent and -independent activation of mitogen-activated protein kinases. Biochem J 320:939-946.
32. Belham CM, Scott PH, Twomey DP, Gould GW, Wadsworth RM and Plevin R (1997) Evidence that thrombin-stimulated DNA synthesis in pulmonary arterial fibroblasts involves phosphatidylinositol 3-kinase-dependent p70 ribosomal S6 kinase activation. Cell Signalling 9:109-116.
33. Benka ML, Lee M, Wang GR, Buckman S, Burlacu A, Cole L, DePina A, Dias P, Granger A, Grant B, Haywardlester A, Karki S, Mann S, Marcu O, Nussenzweig A, Piepenhagen P, Raje M, Roegiers F, Rybak S, Salic A, Smithhall J, Waters J, Yamamoto N, Yanowitz J, Yeow K, Busa WB and Mendelsohn ME (1995) The thrombin receptor in human platelets is coupled to a GTP binding protein of the G alpha q family. FEBS Lett 363:49-52.
34. Bernard-Perrone F, Carrere J, Renaud W, Moriscot C, Thoreux K, Bernard P, Servin A, Balas D and Senegas-Balas F (1998) Pancreatic trypsinogen 1 expression during cell growth and differentiation of two colon carcinoma cells. Am J Physiol-Gastroint Liver Physiol 37:G1077-G1086.
35. Bernatowicz MS, Klimas CE, Hartl KS, Peluso M, Allegretto NJ and Seiler SM (1996) Development of potent thrombin receptor antagonist peptides. J Med Chem 39:4879-4887.
36. Berndt MC, Gregory C, Dowden G and Castaldi PA (1986) Thrombin interactions with platelet membrane-proteins. Ann N Y Acad Sci 485:374-386.
37. Bertog M, Letz B, Kong WY, Steinhoff M, Higgins MA, Bielfeld-Ackermann A, Fromter E, Bunnett NW and Korbmacher C (1999) Basolateral proteinase-activated receptor (PAR-2) induces chloride secretion in M-1 mouse renal cortical collecting duct cells. J Physiol (Lond) 521:3-17.
38. Bischoff R, Cordier Y, Rasmussen UB, Schlesinger Y, Gachet C, Jaquinod M, Tripet B, Chong PCS and Pavirani A (1994) Synthesis and characterization of photoactivatible peptide agonists of the human thrombin receptor. FEBS Lett 349:301-306.
39. Bizios R, Lai L, Fenton JWD and Malik AB (1986) Thrombin-induced chemotaxis and aggregation of neutrophils. J Cell Physiol 128:485-490.
40. Blackhart BD, Emilsson K, Nguyen D, Teng W, Martelli AJ, Nystedt S, Sundelin J and Scarborough RM (1996) Ligand cross-reactivity within the protease-activated receptor family. J Bioll Chem 271:16466-16471.
41. Blank CA and Brantly M (1994) Clinical features and molecular characteristics of alpha-1-antitrypsin deficiency. Ann Allergy 72:105-121.
42. Bohm S, Grady E and Bunnett NW (1997) Mechanisms attenuating signaling by G-protein coupled receptors. Biochem J 322:1-18.
43. Bohm SK, Khitin LM, Grady EF, Aponte G, Payan DG and Bunnett NW (1996a) Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. J Biol Chem 271:22003-22012.
44. Bohm SK, Kong WY, Bromme D, Smeekens SP, Anderson DC, Connolly A, Kahn M, Nelken NA, Coughlin SR, Payan DG and Bunnett NW (1996b) Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 314:1009-1016.
45. Bono F, Lamarche I and Herbert JM (1997) Induction of vascular smooth muscle cell growth by selective activation of the proteinase activated receptor-2 (PAR-2). Biochem Biophys Res Commun 241:762-764.
46. Bouton MC, Jandrotperrus M, Moog S, Cazenave JP, Guillin MC and Lanza F (1995) Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system. Biochem J 305:635-641.
47. Brass LF, Manning DR, Williams AG, Woolkalis MJ and Poncz M (1991) Receptor and G protein-mediated responses to thrombin in HEL cells. J Biol Chem 266: 958-965.
48. Brass LF, Pizarro S, Ahuja M, Belmonte E, Blanchard N, Stadel JM and Hoxie JA (1994) Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J Biol Chem 269:2943-2952.
49. Bretschneider E, Kaufmann R, Braun M, Wittpoth M, Glusa E, Nowak G and Schror K (1999) Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells. Br J Pharmacol 126:1735-1740.
50. Buckler AJ, Chang DD, Graw SL, Brook JD, Haber DA, Sharp PA and Housman DE (1991) Exon amplification - a strategy to isolate mammalian genes based on RNA splicing. Proc Natl Acad Sci USA 88:4005-4009.
51. Camerer E, Huang W and Coughlin SR (2000) Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad USA 97:5255-5260.
52. Carbajal JM, Gratrix ML, Yu CH and Schaeffer RC (2000) Rock mediates thrombin's endothelial barrier dysfunction. Am J Physiol-Cell Physiol 279:C195-C204.
53. Carney DH, Glenn KC and Cunningham DD (1978) Conditions which affect initiation of animal cell division by trypsin and thrombin. J Cell Physiol 95:13-22.
54. Carney DH, Mann R, Redin WR, Pernia SD, Berry D, Heggers JP, Hayward PG, Robson MC, Christie J, Annable C, Fenton JW and Glenn KC (1992) Enhancement of incisional wound-healing and neovascularisation in normal rats by thrombin and synthetic thrombi n receptor activating peptides. J Clin Invest 89:1469-1477.
55. Carr MJ, Schechter NM and Undem BJ (2000) Trypsin-induced, neurokinin-mediated contraction of guinea pig bronchus. Am J Respir Crit Care Med 162: 1662-1667.
56. Cavanaugh KP, Gurwitz D, Cunningham DD and Bradshaw RA (1990) Reciprocal modulation of astrocyte stellation by thrombin and protease nNexin-1. J Neurochem 54:1735-1743.
57. Ceruso MA, McComsey DF, Leo GC, Andrade-Gordon P, Addo MF, Scarborough RM, Oksenberg D and Maryanoff BE (1999) Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies. Bioorg Med Chem 7:2353-2371.
58. Chambers RC, Dabbagh K, McAnulty RJ, Gray AJ, Blanc-Brude OP and Laurent GJ (1998) Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1. Biochem J 333:121-127.
59. Chao BH, Kalkunte S, Maraganore JM and Stone SR (1992) Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor. Biochemistry 31:6175-6178.
60. Chen J, Ishii M, Wang L, Ishii K and Coughlin SR (1994a) Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J Biol Chem 269: 16041-16045.
61. Chen LB and Buchanan JM (1975) Mitogenic activity of blood components. I. Thrombin and prothrombin. Proc Natl Acad Sci USA 72:131-135.
62. Chen LB, Teng NNH and Buchanan JM (1976) Mitogenicity of thrombin and surface alterations on mouse splenocytes. Exp Cell Res 101:41-46.
63. Chen X, Earley K, Luo W, Lin SH and Schilling WP (1996a) Functional expression of a human thrombin receptor in Sf9 insect cells: evidence for an active tethered ligand. Biochem J 314:603-611.
64. Chen Y, Grall D, Salcini AE, Pelicci PG, Pouyssegur J and Van Obberghen-Schilling E (1996b) She adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor. EMBO J 15:1037-1044.
65. Chen YH, Pouyssegur J, Courtneidge SA and Van Obberghen-Schilling E (1994b) Activation of Sre family kinase-activity by the G-protein-coupled thrombin receptor in growth responsive fibroblasts. J Biol Chem 269:27372-27377.
66. Cheng J, Baldassare JJ and Raben DM (1999) Dual coupling of the alpha-thrombin receptor to signal-transduction pathways involving phosphatidylinositol and phosphatidylcholine metabolism. Biochem J 337:97-104.
67. Cheung WM, Andrade-Gordon P, Derian CK and Damiano BP (1998) Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo. Can J Physiol Pharmacol 76:16-25.
68. Cheung WM, D'Andrea MR, Andrade-Gordon P and Damiano BP (1999) Altered vascular injury responses in mice deficient in protease-activated receptor-1. Arteriosclerosis Thromb Vasc Biol 19:3014-3024.
69. Choi BH, Suzuki M, Kim TS, Wagner SL and Cunningham DD (1990) Protease nexin-1-localization in the human brain suggests a potective role against extravasated serine protreases. Am J Pathol 137:741-747.
70. Choi Y and Fuchs E (1990) TGF-beta and retinoic acid - regulators of growth and modifiers of differentiation in human epidermal cells. Cell Regul 1:791-809.
71. Choudhury GG, Marra F and Abboud HE (1996) Thrombin stimulates association of src homology domain containing adaptor protein Nck with pp125 (FAK). Am J Physiol-Renal Fluid Electrolyte Physiol 39:F295-F300.
72. Chow JM, Moffatt JD and Cocks TM (2000) Effect of protease-activated receptor (PAR)-1, -2 and -4-activating peptides, thrombin and trypsin in rat isolated airways. Br J Pharmacol 131:1584-1591.
73. Cicala C, Pinto A, Bucci M, Sorrentino R, Walker B, Harriot P, Cruchley A, Kapas S, Howells GL and Cirino G (1999) Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation 99:2590-2597.
74. Cichowski K, McCormick F and Brugge JS (1992) p21rasGAP association with Fyn, Lyn, and Yes in thrombin-activated platelets. J Biol Chem 267:5025-5028.
75. Coakley RJ, Taggart C, O'Neill S and McElvaney NG (2001) Alpha 1-antitrypsin deficiency biological answers to clinical questions. Am J Med Sci 321:33-41.
76. Cocks TM, Fong B, Chow JM, Anderson GP, Frauman AG, Goldie RG, Henry PJ, Carr MJ, Hamilton JR and Moffatt JD (1999a) A protective role for protease-activated receptors in the airways. Nature (Land) 398:156-160.
77. Cocks TM and Moffatt JD (2000) Protease-activated receptors: sentries for inflammation? Trends Pharmacol Sci 21:103-108.
78. Cocks TM and Sobey CG (1998) Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo. FASEB J 12:5519.
79. Cocks TM, Sozzi V, Moffatt JD and Selemidis S (1999b) Protease-activated receptors mediate apamin-sensitive relaxation of mouse and guinea pig gastrointestinal smooth muscle. Gastroenterology 116:586-592.
80. Coller BS, Springer KT, Scudder LE, Kutok JL, Ceruso M and Prestwich GD (1993) Substituting isoserine for serine in the thrombin receptor activation peptide SFLLRN confers resistance to aminopeptidase M-induced cleavage and inactivation. J Biol Chem 268:20741-20743.
81. Coller BS, Ward P, Ceruso M, Scudder LE, Springer K, Kutok J and Prestwich GD (1992) Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M. Biochemistry 31:11713-11720.
82. Collins LR, Minden A, Karin M and Brown JH (1996) G alpha (12) stimulates c-Jun NH2-terminal kinase through the small G proteins Ras and Rac. J Biol Chem 271:17349-17353.
83. Collins LR, Ricketts WA, Olefsky JM and Brown JH (1997) The G12 coupled thrombin receptor stimulates mitogenesis through the She SH2 domain. Oncogene 15: 595-600.
84. Compton SJ, Cairns JA, Holgate ST and Walls AF (1998) The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: Tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J Immunol 161:1939-1946.
85. Compton SJ, Cairns JA, Palmer KJ, Al-Ani B, Hollenberg MD and Walls AF (2000) A polymorphic protease activated receptor-2 (PAR-2) displaying reduced sensitivity to trypsin and differential responses to par agonists. J Biol Chem 275:39207-39212.
86. Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr and Coughlin SR (1996) Role of the thrombin receptor in development and evidence for a second receptor. Nature (Lond) 381:516-519.
87. Connolly TM, Condra C, Feng DM, Cook JJ, Stranieri MT, Reilly CF, Nutt RF and Gould RJ (1994) Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thrombosis Haemostasis 72:627-633.
88. Cook JJ, Sitko GR, Bednar B, Condra C, Mellott MJ, Feng DM, Nutt RF, Shafer JA, Gould RJ and Connolly TM (1995) An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African-green monkey. Circulation 91:2961-2971.
89. Corvera CU, Dery O, McConalogue K, Bohm SK, Khitin LM, Caughey GH, Payan DG and Bunnett NW (1997) Mast cell tryptase regulates rat colonie myocytes through proteinase-activated receptor 2. J Clin Invest 100:1383-13893.
90. Corvera CU, Dery O, McConalogue K, Gamp P, Thoma M, Al-Ani B, Caughey GH, Hollenberg MD and Bunnett NW (1999) Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J Physiol (Lond) 517:741-756.
91. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature (Lond) 407:258-264.
92. Crouch MF (1997) Regulation of thrombin-induced stress fibre formation in Swiss 3T3 cells by the 70-kDa S6 kinase. Biochem Biophys Res Commun 233:193-199.
93. Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR and Tipping PG (2000) Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191:455-461.
94. Dabbagh K, Laurent GJ, McAnulty RJ and Chambers RC (1998) Thrombin stimulates smooth muscle cell procollagen synthesis and mRNA levels via a PAR-1 mediated mechanism. Thromb Haemostasis 79:405-409.
95. Damiano BP, Cheung WM, Mitchell JA and Falotico R (1996a) Cardiovascular actions of thrombin receptor activation in vivo. J Pharmacol Exp Ther 279:1365-1378.
96. Damiano BP, Cheung WM, Santulli RJ, FungLeung WP, Ngo K, Ye RD, Darrow AL, Derian CK, DeGaravilla L and Andrade-Gordon P (1999a) Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J Pharmacol Exp Ther 288:671-678.
97. Damiano BP, D'Andrea MR, DeGaravilla L, Cheung WM and Andrade-Gordon P (1999b) Increased expression of protease activated receptor-2 (PAR-2) in balloon-injured rat carotid artery. Thromb Haemostasis 81:808-814.
98. Damiano BP, Mitchell JA, Cheung WM and Falotico R (1996b) Activation of vascular thrombin receptors mediates cardiac response to alpha-thrombin in isolated, perfused guinea pig heart. Am J Physiol-Heart Circ Physiol 39:H1585-H1596.
99. D'Andrea MR, Derian CK, Leturcq D, Baker SM, Brunmark A, Ling P, Darrow AL, Santulli RJ, Brass LF and Andrade-Gordon P (1998) Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem 46:157-164.
100. Daniel TO, Gibbs VC, Milfay DF, Garovoy MR and Williams LT (1986) Thrombin stimulates C-sis gene-expression in microvascular endothelial-cells. J Biol Chem 261:9579-9582.
101. Dardik R, Savion N, Kaufmann Y and Varon D (1998) Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Br J Cancer 77:2069-2075.
102. Darrow AL, Fung-Leung WP, Ye RD, Santulli RJ, Cheung WM, Derian CK, Burns CL, Damiano BP, Zhou L, Keenan CM, Peterson PA and Andrade-Gordon P (1996) Biological consequences of thrombin receptor deficiency in mice. Thrombosis Haemostasis 76:860-866.
103. Davey MG and Luscher EF (1967) Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets. Nature (Lond) 216:857-858.
104. Davie EW, Fujikawa K and Kisiel W (1991) The coagulation cascade - initiation, maintenance, and regulation. Biochemistry 80:10363-10370.
105. Davis ID, Burke B, Freese D, Sharp HL and Kim YK (1992) The pathological spectrum of the nephropathy associated with alpha-1-antitrypsin deficiency. Hum Pathol 23:07-62.
106. Debeir T, Vige X and Benavides J (1997) Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes. Eur J Pharmacol 323:111-117.
107. Deblois D, Drapeau G, Petitclerc E and Marceau F (1992) Synergism between the contractile effect of epidermal growth factor and that of Des-Arg9-bradykinin or of alpha-thrombin in rabbit aortic rings. Br J Pharmacol 105:959-967.
108. DeFea K, Schmidlin F, Dery O, Grady EF and Bunnett NW (2000a) Mechanisms of initiation and termination of signalling by neuropeptide receptors: a comparison with the proteinase-activated receptors. Biochem Soc Trans 28:419-426.
109. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD and Bunnett NW (2000b) Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148:1267-1281.
110. Delafontaine P, Anwar A, Lou H and Ku L (1996) G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest 97:139-145.
111. Demarco L, Mazzucato M, Masotti A, Fenton JW and Ruggeri ZM (1991) Function of glycoprotein Ib-alpha in platelet activation induced by alpha-thrombin. J Biol Chem 266:23776-23783.
112. Demarco L, Mazzucato M, Masotti A and Ruggeri ZM (1994) Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib-alpha. J Biol Chem 269:6478-6484.
113. Demetrick DJ, Dewald GW, Lanman J and Bahou WF (1996) The thrombin receptor gene is centromeric to the common proximal breakpoint in patients with the 5q-syndrome: identification of a previously unrecognized chromosome 5 inversion. Br J Haematol 92:339-343.
114. Derian CK, Eckardt AJ and Andrade-Gordon P (1997) Differential regulation of human keratinocyte growth and differentiation by a novel family of protease-activated receptors. Cell Growth Differen 8:743-749.
115. Dery O, Corvera CU, Steinhoff M and Bunnett NW (1998) Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol-Cell Physiol 43:C1429-C1452.
116. Dery O, Thoma MS, Wong H, Grady EF and Bunnett NW (1999) Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein-beta-arrestin-dependent endocytosis of a proteinase receptor. J Biol Chem 274:18524-18535.
117. Detwiler TC and Feinman RD (1973) Kinetics of the thrombin-induced release of adenosine triphosphate by platelets. Comparison with release of calcium. Biochemistry 12:2462-2468.
118. Dong JF, SaeTung G and Lopez JA (1997) Role of glycoprotein V in the formation of the platelet high-affinity thrombin-binding site. Blood 89:4355-4363.
119. Donovan FM, Pike CJ, Cotman CW and Cunningham DD (1997) Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 17:5316-5326.
120. Ehrenreich H, Costa T, Clouse KA, Pluta RM, Ogino Y, Coligan JE and Burd PR (1993) Thrombin is a regulator of astrocytic endothelin-1. Brain Res 600:201-207.
121. Eidt JF, Ashton J, McNatt J, Buja LM and Willerson JT (1988) Thrombin is an important mediator of platelet-aggregation in vivo. Clin Res 36:A603-A603.
122. Ekholm IE, Brattsand M and Egelrud T (2000) Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J Invest Dermatol 114:56-63.
123. Elliott JT, Hoekstra WJ, Maryanoff BE and Prestwich GD (1999) Photoactivatable peptides based on BMS-197525: a potent antagonist of the human thrombin receptor (PAR-1). Bioorg Med Chem Lett 9:279-284.
124. Ellis CA, Tiruppathi C, Sandoval R, Niles WD and Malik AB (1999) Time course of recovery of endothelial cell surface thrombin receptor (PAR-1) expression. Am J Physiol 276:C38-45.
125. Emilsson K, Wahlestedt C, Sun MK, Nystedt S, Owman C and Sundelin J (1997) Vascular effects of proteinase-activated receptor 2 agonist peptide. J Vasc Res 34:267-272.
126. Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC and Aepfelbacher M (1998) Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem 273:21867-21874.
127. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I and Bar-Shavit R (1998) Thrombin receptor overexpression in malignant and physiological invasion processes. Nature Med 4:909-914.
128. Faruqi TR, Weiss EJ, Shapiro MJ, Huang W and Coughlin SR (2000) Structure-function analysis of protease-activated receptor 4 tethered ligand peptides - determinants of specificity and utility in assays of receptor function. J Biol Chem 275:19728-19734.
129. Fee JA, Monsey JD, Handler RJ, Leonis MA, Mullaney SR, Hope HM and Silbert DF (1984) A Chinese hamster fibroblast mutant defective in thrombin-induced signaling has a low level of phospholipase C-beta 1. J Biol Chem 269:21699-21708.
130. Feng DM, Gardell SJ, Lewis SD, Bock MG, Chen ZG, Freidinger RM, Naylor Olsen AM, Ramjit HG, Weltmann R, Baskin EP, Lynch JJ, Lucas R, Shafer JA, Dancheck KB, Chen IW, Mao SS, Krueger JA, Hare TH, Mulichak AM and Vacca JP (1997) Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 position. J Med Chem 40:3726-3733.
131. Feng DM, Veber DF, Connolly TM, Condra C, Tang MJ and Nutt RF (1995) Development of a potent thrombin receptor-ligand. J Med Chem 38:4125-4130.
132. Ferguson SSG, Downey WE, Colapietro AM, Barak LS, Menard L and Caron MG (1996) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science (Wash DC) 271:363-366.
133. Fernandez-Patron C, Zhang YL, Radomski MN, Hollenberg MD and Davidge ST (1999) Rapid release of matrix metalloproteinaae (MMP)-2 by thrombin in the rat aorta: modulation by protein tyrosine kinase/phosphatase. Thromb Haemostasis 82:1353-1357.
134. Fortin PR, Fraser RS, Watts CS and Esdaile JM (1991) Alpha-1 antitrypsin deficiency and systemic necrotizing vasculitis. J Rheumatol 18:1613-1616.
135. Fox MT, Harriott P, Walker B and Stone SR (1997) Identification of potential activators of proteinase-activated receptor-2. FEBS Lett 417:267-269.
136. Fujita T, Nose T, Nakajima M, Inoue Y, Costa T and Shimohigashi Y (1999) Design and synthesis of para-fluorophenylalanine amide derivatives as thrombin receptor antagonists. J Biochem 126:174-179.
137. Fukuhara S, Marinissen MJ, Chiariello M and Gutkind JS (2000) Signaling from G protein-coupled receptors to ERK5/big MAPK 1 involves G alpha(q) and G alpha(12/13) families of heterotrimeric G proteins - evidence for the existence of a novel Ras and Rho-independent pathway. J Biol Chem 275:21730-21736.
138. Fukuhara S, Murga C, Zohar M, Igishi T and Gutkind JS (1999) A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho. J Biol Chem 274:5868-5879.
139. Ganguly P (1974) Binding of thrombin to human platelets. Nature (Lond) 274:306-307.
140. 2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth-factor messenger-RNA expression in cultured endothelium. J Cell Physiol 156:541-549.
141. Garcia JGN, Siflingerbirnboim A, Bizios R, Delvecchio PJ, Fenton JW and Malik AB (1986) Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol 128:96-104.
142. Gerszten RE, Chen J, Ishii M, Ishii K, Wang L, Nanevicz T, Turck CW, Vu TK and Coughlin SR (1994) Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature (Lond) 368:648-651.
143. Gingrich MB, Junge CE, Lyuboslavsky P and Traynelis SF (2000) Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci 20:4582-4595.
144. Gingrich MB and Traynelis SF (2000) Serine proteases and brain damage - is there a link? Trends Neurosci 23:399-407.
145. Godin D, Rioux F, Marceau F and Drapeau G (1995) Mode of action of thrombin in the rabbit aorta. Br J Pharmacol 115:903-908.
146. Golden CL, Nick HS and Visner GA (1998) Thrombin regulation of endothelin-1 gene in isolated human pulmonary endothelial cells. Am J Physiol-Lung Cell Mol Physiol 18:L854-L863.
147. Goodman OB, Krupnick JG, Santini F, Gurevich W, Penn RB, Gagnon AW, Keen JH and Benovic JL (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta(2)-adrenergic receptor. Nature (Lond) 383:447-450.
148. Grabham P and Cunningham DD (1995) Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways - involvement of tyrosine phosphorylation. J Neurochem 64:583-591.
149. Grand RJ, Grabham PW, Gallimore MJ and Gallimore PH (1989) Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: independence from blood coagulation. EMBO J 8:2209-2215.
150. Grand RJ, Turnell AS and Grabham PW (1996) Cellular consequences of thrombin-receptor activation. Biochem J 313:353-368.
151. Greco NJ and Jamieson GA (1991) High and moderate affinity pathways for alpha-thrombin-induced platelet activation. Proc Soc Exp Biol Med 198:792-799.
152. 2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide. Biochemistry 35:915-921.
153. 2+] induced by alpha-thrombin. Biochemistry 35:906-914.
154. Green BT, Bunnett NW, Kulkarni-Narla A, Steinhoff M and Brown DR (2000) Intestinal type 2 proteinase-activated receptors expression in opioid-sensitive secretomotor neural circuits that mediate epithelial ion transport. J Pharmacol Exp Ther 295:410-416.
155. Green GM and Nasset ES (1980) Importance of bile in regulation of intraluminal proteolytic enzyme activities in the rat. Gastroenterology 79:695-702.
156. Gronke RS, Bergman BL and Baker JB (1987) Thrombin interaction with platelets-influence of a platelet protease nexin. J Biol Chem 262:3030-3036.
157. Gurwitz D and Cunningham DD (1988) Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci USA 85:3440-3444.
158. Hamilton JR, Chow JM and Cocks TM (1999) Protease-activated receptor-2 turnover stimulated independently of receptor activation in porcine coronary endothelial cells. Br J Pharmacol 127:617-622.
159. Hamilton JR, Nguyen PB and Cocks TM (1998) Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries. Circ Res 82:1306-1311.
160. Hammes S, Shapiro M and Coughlin S (1999) Shutoff and agonist-triggered internalization of protease-activated receptor 1 can be separated by mutation of putative phosphorylation sites in the cytoplasmic tail. Biochemistry 38:9308-9316.
161. Hammes SR and Coughlin SR (1999) Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand. Biochemistry 38:2486-2493.
162. Haralabopoulos GC, Grant DS, Kleinman HK and Maragoudakis ME (1997) Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am J Physiol-Cell Physiol 42:C239-C245.
163. Harmon JT and Jamieson GA (1986a) The glycocalicin portion of platelet glycoprotein Ib expresses both high and moderate affinity receptor-sites for thrombin - a soluble radioreceptor assay for the interaction of thrombin with platelets. J Biol Chem 261:3224-3229.
164. Harmon JT and Jamieson GA (1986b) Platelet activation by alpha-thrombin is a receptor-mediated event. Ann N Y Acad Sci 485:387-395.
165. Harvima IT, Naukkarinen A, Paukkonen K, Harvima RJ, Aalto ML, Schwartz LB and Horsmanheimo M (1993) Mast-cell tryptase and chymase in developing and mature psoriatic lesions. Arch Dermatol Res 285:184-192.
166. Hastings GA, Coleman TA, Haudenschild CC, Stefansson S, Smith KP, Barlow R, Cherry S, Sandkvist M and Lawrence DA (1997) Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized in primary neurons - implications for the regulation of motor learning and neuronal survival. J Biol Chem 272:33062-33067.
167. Hattori R, Hamilton KK, Fugate RD, McEver RP and Sims PJ (1989) Stimulated secretion of endothelial Von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein Gmp-140. J Biol Chem 264:7768-7771.
168. Hauck RW, Schulz C, Schomig A, Hoffman RK and Panettieri RA (1999) Alpha-thrombin stimulates contraction of human bronchial rings by activation of protease-activated receptors. Am JPhysiol-Lung Cell MolPhysiol 21:L22-L29.
169. Hauptmann J and Markwardt F (1992) Pharmacological aspects of the development of selective synthetic thrombin inhibitors as anticoagulants. Semin Thromb Hemostasis 18:200-217.
170. Hayes KL and Tracy PB (1999) The platelet high affinity binding site for thrombin mimics hirudin, modulates thrombin-induced platelet activation, and is distinct from the glycoprotein Ib-IX-V complex. J Biol Chem 274:972-980.
171. Hein L, Ishii K, Coughlin SR and Kobilka BK (1994) Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. J Biol Chem 269:27719-27726.
172. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G and Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature (Lond) 391:591-594.
173. Henrikson KP, Salazar SL, Fenton JW and Pentecost BT (1999) Role of thrombin receptor in breast cancer invasiveness. Br J Cancer 79:401-406.
174. Herbert JM, Dupuy E, Laplace MC, Zini JM, Bar Shavit R and Tobelem G (1994) Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochem J 303:227-231.
175. Hermanns JF, Petit L, Martalo O, Pierard-Franchimont C, Cauwenbergh C and Pierard GE (2000) Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: effect of depigmenting agents. Dermatology 201:118-122.
176. Hernandez-Rodriguez NA, Cambrey AD, Harrison NK, Chambers RC, Gray AJ, Southcott AM, Dubois RM, Black CM, Scully MF, McAnulty RJ and Laurent GJ (1995) Role of thrombin in pulmonary fibrosis. Lancet 346:1071-1073.
177. Hoekstra WJ, Hulshizer BL, McComsey DF, Andrade-Gordon P, Kauffman JA, Addo MF, Oksenberg D, Scarborough RM and Maryanoff BE (1998) Thrombin receptor (PAR-1) antagonists. Heterocycle-based peptidomimetics of the SFLLR agonist motif. Bioorg Med Chem Lett 8:1649-1654.
178. Hoffmann H, Siebeck M, Spannagl M, Weis M, Geiger R, Jochum M and Fritz H (1990) Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs. Am Rev Respir Dis 142:782-788.
179. Hollenberg MD (1996) Protease-mediated signalling: new paradigms for cell regulation and drug development. Trends Pharmacol Sci 17:3-6.
180. Hollenberg MD, Saifeddine M and Al-Ani B (1996) Proteinase-activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides. Mol Pharmacol 49:229-233.
181. Hollenberg MD, Saifeddine M, Al-Ani B and Gui Y (1999) Proteinase-activated receptor 4 (PAR(4)): action of PAR(4)-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR(1) and PAR(2). Can J Physiol Pharmacol 77:458-464.
182. Hollenberg MD, Saifeddine M, Al-Ani B and Kawabata A (1997) Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 75:832-841.
183. Hollenberg MD, Saifeddine M and Zwiers H (2000) Proteinase-activated receptors (PARs) activation of PAR(1) and PAR(2) by a proteolytic fragment of the neuronal growth associated protein B-50/GAP-43. Can J Physiol Pharmacol 78:81-85.
184. Hollenberg MD, Yang SG, Laniyonu AA, Moore GJ and Saifeddine M (1992) Action of thrombin receptor polypeptide in gastric smooth muscle - Identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity. Mol Pharmacol 42:186-191.
185. Howells GL, Macey MG, Chinni C, Hou L, Fox MT, Harriott P and Stone SR (1997) Proteinase-activated receptor-2: expression by human neutrophils. J Cell Sci 110:881-887.
186. Hoxie JA, Ahuja M, Belmonte E, Pizarro S, Parton R and Brass LF (1993) Internalization and recycling of activated thrombin receptors. J Biol Chem 268:13756-13763.
187. Huang YQ, Li JJ and Karpatkin S (2000) Thrombin inhibits tumor cell growth in association with up-regulation of p21(waf/cip1) and caspases via a p53-independent, STAT-1-dependent pathway. J Biol Chem 278:6462-6468.
188. Hung DT, Wong YH, Vu TK and Coughlin SR (1992) The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. J Biol Chem 267:20831-20834.
189. Hwa JJ, Ghibaudi L, Williams P, Chintala M, Zhang RM, Chatterjee M and Sybertz E (1996) Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Circ Res 78:581-588.
190. Iaccarino G, Rockman HA, Shotwell KF, Tomhave ED and Koch WJ (1998) Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. Am J Physiol 275:H1298-H1306.
191. Ido M, Hayashi T, Gabazza E and Suzuki K (2000) Identification of a novel 33 kDa ser/thr kinase that phosphorylates the cytoplasmic tail of protease-activated receptor 1 (thrombin receptor) in human platelets. Thromb Haemostasia 83:617-621.
192. 2+-dependent activation of the 33-kDa protein kinase transmits thrombin receptor signals in human platelets. Thromb Haemostasis 76:439-443.
193. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T and Coughlin SR (1997) Protease-activated receptor 3 is a second thrombin receptor in humans. Nature (Lond) 386:502-506.
194. Ishihara H, Zeng D, Connolly AJ, Tam C and Coughlin SR (1998) Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin. Blood 91, 4152-4157.
195. Ishii K, Chen J, Ishii M, Koch WJ, Freedman NJ, Lefkowitz RJ and Coughlin SR (1994) Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. J Biol Chem 269:1125-1130.
196. Ishii K, Gerszten R, Zheng YW, Welsh JB, Turck CW and Coughlin SR (1995) Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and role of the P3 aspartate. J Biol Chem 270:16435-16440.
197. Ishii K, Hein L, Kobilka B and Coughlin SR (1993) Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J Biol Chem 268:9780-9786.
198. Jenkins AL, Howells GL, Scott E, Lebonniec BF, Curtis MA and Stone SR (1995) The response to thrombin of human neutrophils - evidence for 2 novel receptors. J Cell Sci 108:3059-3066.
199. Jewell-Motz EA, Small KM, Theiss CT and Liggett SB (2000) alpha(2A)/alpha(2C)-adrenergic receptor third loop chimera show that agonist interaction with receptor subtype backbone establishes G protein-coupled receptor kinase phosphorylation. J Biol Chem 275:28989-28993.
200. Johanson SO, Naccache PA and Crouch MF (1999) A p85 subunit-independent p110 alpha PI 3-kinase colocalizes with p70 S6 kinase on actin stress fibers and regulates thrombin-stimulated stress fiber formation in Swiss 3T3 cells. Exp Cell Res 248:223-233.
201. Kahan C, Seuwen K, Meloche S and Pouyssegur J (1992) Coordinate, biphasic activation of P44 mitogen-activated protein-kinase and S6 kinase by growth-factors in hamster fibroblasts - evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition. J Biol Chem 267: 13369-13375.
202. Kahn ML, Nakanishi Matsui M, Shapiro MJ, Ishihara H and Coughlin SR (1999) Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 103:879-887.
203. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV Jr, Tam C and Coughlin SR (1998) A dual thrombin receptor system for platelet activation. Nature (Lond) 394:690-694.
204. Kanke T, Macfarlane S, Seatter M and Plevin R (2000) Regulation of c-Jun-N-terminal kinase and p38 MAP kinase by proteinase activated receptor-2 in human skin epithelial cell line NCT2544. Br J Pharmacol 129:23P.
205. Kanthou C, Kanse SM, Kakkar W and Benzakour O (1996) Involvement of pertussis toxin-sensitive and -insensitive G proteins in alpha-thrombin signalling on cultured human vascular smooth muscle cells. Cell Signalling 8:59-66.
206. Kato Y, Kita Y, Nishio M, Hirasawa Y, Ito K, Yamanaka T, Motoyama Y and Seki J (1999) In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist. Eur J Pharmacol 384:197-202.
207. Kaufmann R, Patt S, Zieger M, Kraft R and Nowak G (1999) Presence of the proteinase-activated receptor-2 (PAR-2) in human brain tumor cells - trypsin- and SLIGRL-induced calcium response in primary cultured meningiomas. Cancer Lett 139:109-113.
208. 2+](i) mobilization in human astrocytoma cells. J Cancer Res Clin Oncol 126: 91-94.
209. Kaufmann R, Schafberg H and Nowak G (1998) Proteinase-activated receptor-2-mediated signaling and inhibition of DNA synthesis in human pancreatic cancer cells. Int J Pancreatol 24:97-102.
210. Kawabata A, Kuroda R, Kuroki N, Nishikawa H and Kawai K (2000a) Dual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease-activated receptors (PARs): a novel role for PAR-4 as opposed to PAR-1. Br J Pharmacol 131:578-584.
211. Kawabata A, Kuroda R, Kuroki N, Nishikawa H, Kawai K and Araki H (2000d) Characerization of the protease-activated receptor-1 mediated contraction and relaxation in the rat duodenal smooth muscle. Life Sci 67:2521-2530.
212. Kawabata A, Kuroda R, Nishikawa H and Kawai K (1999a) Modulation by protease-activated receptors of the rat duodenal motility in vitro: possible mechanisms underlying the evoked contraction and relaxation. Br J Pharmacol 128:865-872.
213. Kawabata A, Morimoto N, Nishikawa H, Kuroda R, Oda Y and Kakehi K (2000b) Activation of protease-activated receptor-2 (PAR-2) triggers mucin secretion in the rat sublingual gland. Biochem Biophys Res Commun 270:298-302.
214. Kawabata A, Nishikawa H, Kuroda R, Kawai K and Hollenberg MD (2000c) Proteinase-activated receptor-2 (PAR-2) regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice. Br J Pharmacol 129:1808-1814.
215. Kawabata A, Saifeddine M, Al-Ani B, Leblond L and Hollenberg MD (1999b) Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands. J Pharmacol Exp Ther 288:358-370.
216. Kinlough-Rathbone RL, Perry DW, Guccione MA, Rand ML and Packham MA (1993) Degranulation of human platelets by the thrombin receptor peptide SFLLRN: comparison with degranulation by thrombin. Thromb Haemostasis 70:1019-1023.
217. Klepfish A, Greco MA and Karpatkin S (1993) Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix. Int J Cancer 53:978-982.
218. Kohno M, Yokokawa K, Horio T, Yasunari K, Murakawa K, Ikeda M and Takeda T (1992) Release mechanism of endothelin-1 and big endothelin-1 after stimulation with thrombin in cultured porcine endothelial cells. J Vasc Res 29:56-63.
219. Komuro T, Miwa S, Minowa T, Okamoto Y, Enoki T, Ninomiya H, Zhang XF, Uemura Y, Kikuchi Hand Masaki T (1997) The involvement of a novel mechanism distinct from the thrombin receptor in the vasocontraction induced by trypsin. Br J Pharmacol 120:851-856.
220. Kong WY, McConalogue K, Khitin LM, Hollenberg MD, Payan DG, Bohm SK and Bunnett NW (1997) Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc Natl Acad Sci USA 94:8884-8889.
221. Koshikawa N, Hasegawa S, Nagashima Y, Mitsuhashi K, Tsubota Y, Miyata S, Miyagi Y, Yasumitsu H and Miyazaki K (1998) Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am J Pathol 153:937-944.
222. Koshikawa N, Nagashima Y, Miyagi Y, Mizushima H, Yanoma S, Yasumitsu H and Miyazaki K (1997) Expression of trypsin in vascular endothelial cells. FEBS Lett 409:442-448.
223. Krymskaya VP, Penn RB, Orsini MJ, Scott PH, Plevin RJ, Walker TR, Eszterhas AJ, Amrani Y, Chilvers ER and Panettieri RA (1999) Phosphatidylinositol 3-kinase mediates mitogen-induced human airway smooth muscle cell proliferation. Am J Physiol-Lung Cell Mol Physiol 21:L65-L78.
224. Ku DD and Dai J (1997) Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro. J Cardiovasc Pharmacol 30:649-657.
225. Kuliopulos A, Covic L, Seeley SK, Sheridan PJ, Helin J and Costello CE (1999) Plasmin desensitization of the PARI thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 38:4572-4585.
226. LaMorte VJ, Kennedy ED, Collins LR, Goldstein D, Harootunian AT, Brown JH and Feramisco JR (1993) A requirement for Ras protein function in thrombin-stimulated mitogenesis in astrocytoma cells. J Biol Chem 268:19411-19415.
227. Lan RS, Stewart GA and Henry PJ (2000) Modulation of airway smooth muscle tone by protease activated receptor-1, -2, -3 and-4 in trachea isolated from influenza A virus-infected mice. Br J Pharmacol 129:63-70.
228. Langer F, Morys Wortmann C, Kusters B and Storck J (1999) Endothelial protease-activated receptor-2 induces tissue factor expression and von Willebrand factor release. Br J Haematol 105:542-550.
229. Laniyonu AA and Hollenberg MD (1995) Vascular actions of thrombin receptor-derived polypeptides - structure-activity profiles for contractile and relaxant effects in rat aorta. Br J Pharmacol 114:1680-1686.
230. Leong L, Henriksen RA, Kermode JC, Rittenhouse SE and Tracy PB (1992) The thrombin high-affinity binding site on platelets is a negative regulator of thrombin-induced platelet activation. Structure-function studies using two mutant thrombins, Quick I and Quick II. Biochemistry 31:2567-2576.
231. Lerner DJ, Chen M, Tram T and Coughlin SR (1996) Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function. J Biol Chem 271:13943-13947.
232. Linder JR, Kahn ML, Coughlin SR, Sambrano GR, Schauble E, Bernstein D, Foy D, Hafezi-Moghadam A and Ley K (2000) Delayed onset of inflammation in protease-activated receptor-2-defident mice. J Immunol 165:6504-6510.
233. Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie EJ and Pike RN (1998) Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 435:45-48.
234. Lum H, Andersen TT, Fenton JW and Malik AB (1994) Thrombin receptor activation peptide induces pulmonary vasoconstriction. Am J Physiol 266:C448-C454.
235. Lum H and Malik AB (1996) Mechanisms of increased endothelial permeability. Can J Physiol Pharmacol 74:787-800.
236. Ma SF, Dixion EP, Reuning U, Little SP, Johnstone EM, Bang NU, Patterson CE and Garcia JGN (1996) Molecular cloning of the bovine proteolytically-activated thrombin receptor. J Invest Med 44:A244.
237. Macfarlane SR, Kanke T, Scatter M, Davenport E, Paul A and Plevin R (2000) Trypsin stimulates the NF kappa B signalling pathway in NCTC 2544 transfected with human protease-activated receptor-2. Br J Pharmacol 129:21P.
238. Magazine HI, King JM and Srivastava KD (1996) Protease activated receptors modulate aortic vascular tone. Int J Cardiol 53:875-880.
239. Magnaldo I, Pouyssegur J and Paris S (1988) Thrombin exerts a dual effect on stimulated adenylate cyclase in hamster fibroblasts, an inhibition via a GTP-binding protein and a potentiation via activation of protein kinase C. Biochem J 253:711-719.
240. Majumdar M, Seasholtz TM, Goldstein D, de Lanerolle P and Brown JH (1998) Requirement for Rho-mediated myosin light chain phosphorylation in thrombin-stimulated cell rounding and its dissociation from mitogenesis. J Biol Chem 273:10099-10106.
241. Malarkey K, Belham CM, Paul A, Graham A, McLees A, Scott PH and Plevin R (1995) The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem J 309:361-375.
242. Malcolm KC, Chambard JC, Grall D, Pouyssegur J and Van Obberghen-Schilling E (2000) Independent activation of endogenous p21-activated protein kinase-3 (PAK3) and JNK by thrombin in CCL39 fibroblasts. J Cell Physiol 185:235-243.
243. Malik AB, Bizios R, Lai LC and Delvecchio PJ (1986) Thrombin induced adherence of neutrophils (PMN) to endothelial monolayers (ECM). J Cell Biol 103:A195.
244. Maraganore JM, Bourdon P, Jablonski J, Ramachandran KL and Fenton JW (1990) Design and characterization of hirulogs - a novel class of bivalent peptide inhibitors of thrombin. Biochemistry 29:7095-7101.
245. Maragoudakis ME, Tsopanoglou NE, Andriopoulou P and Maragoudakis ME (2000) Effects of thrombin/thrombosis in angiogenesis and tumour progression. Matrix Biol 19:345-351.
246. Martin BM, Feinman RD and Detwiler TC (1975) Platelet stimulation by thrombin and other proteases. Biochemistry 14:1308-1314.
247. Matsoukas J, Hollenberg MD, Mavromoustakos T, Panagiotopoulos D, Alexopulos K, Yamdagni R, Wu Q and Moore GJ (1997) Conformational analysis of the thrombin receptor agonist peptides SFLLR and SFLLR-NH2 by NMR: evidence for a cyclic bioactive conformation. J Protein Chem 16:113-131.
248. Matsoukas JM, Panagiotopoulos D, Keramida M, Mavromoustakos T, Yamdagni R, Wu Q, Moore GJ, Saifeddine M and Hollenberg MD (1996) Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity, J Med Chem 39:3585-3591.
249. Mbebi C, Rohn T, Doyennette M-A, Chevessier F, Jandrot-Perrus M, Hantaï D and Verdière-Sahuqué M (2001) Thrombin receptor induction by injury-related factors in human skeletal muscle cells. Exp Cell Res 263:77-87.
250. McComsey DF, Hecker LR, Andrade-Gordon P, Addo MF and Maryanoff BE (1999) Macrocyclic hexapeptide analogues of the thrombin receptor (PAR-1) activation motif SFLLRN. Bioorg Med Chem Lett 9:255-260.
251. McGregor L, Hanss M, Sayegh A, Calvette JJ, Trzeciak MC, Ville D, Catimel B, Viala JJ, Dechavanne M and McGregor JL (1989) Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoprotein-Iib and glycoprotein-Iiia. Thromb Haemostasis 62:962-967.
252. McNamara CA, Sarembock IJ, Gimple LW, Fenton JWD, Coughlin SR and Owens GK (1993) Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 91:94-98.
253. McNicol A and Robson CA (1997) Thrombin receptor-activating peptide releases arachidonic acid from human platelets: A comparison with thrombin and trypsin. J Pharmacol Exp Ther 281:861-867.
254. Miller S, Sehati N, Romano C and Cotman CW (1996) Exposure of astrocytes to thrombin reduces levels of the metabotropic glutamate receptor mGluR5. J Neurochem 67:1435-1447.
255. Mirza H, Schmidt VA, Derian CK, Jesty J and Bahou WF (1997) Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell alpha-or beta-tryptases. Blood 90:3914-3922.
256. Mirza H, Yatsula V and Bahou WF (1996) The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells -molecular characterization and evidence for functional coupling to the thrombin receptor. J Clin Invest 97:1705-1714.
257. Mitchell CA, Jefferson AB, Bejeck BE, Brugge JS, Deuel TF and Majerus PW (1990) Thrombin-stimulated immunoprecipitation of phosphatidylinositol 3-kinase from human platelets. Proc Natl Acad Sci USA 87:9396-9400.
258. Mitsui H, Maruyama T, Kimura S and Takuwa Y (1997) Thrombin-specific activation of c-jun N-terminal kinase and P38 mitogen-activated protein kinase in human liver cells. Hepatology 26:546.
259. Mitsui H, Maruyama T, Kimura S and Takuwa Y (1998) Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells. Hepatology 27:1362-1367.
260. Miyata S, Koshikawa N, Higashi S, Miyagi Y, Nagashima Y, Yanoma S, Kato Y, Yasumitsu H and Miyazaki K (1999) Expression of trypsin in human cancer cell lines and cancer tissues and its tight binding to soluble form of Alzheimer amyloid precursor protein in culture. J Biochem 125:1067-1076.
261. Miyata S, Koshikawa N, Yasumitsu H and Miyazaki K (2000) Trypsin stimulates integrin alpha(5)beta(1)-dependent adhesion to fibronectin and proliferation of human gastric carcinoma cells through activation of proteinase-activated receptor-2. J Biol Chem 275:4592-4598.
262. Mizuno O, Hirano K, Nishimura J, Kubo C and Kanaide H (2000) Proteolysis and phosphorylation-media ted regulation of thrombin receptor activity in in situ endothelial cells. Eur J Pharmacol 389:13-23.
263. Moffatt JD and Cocks TM (1999) The role of protease-activated receptor-2 (PAR2) in the modulation of beating of the mouse isolated ureter: lack of involvement of mast cells or sensory nerves. Br J Pharmacol 128:860-864.
264. Mohle R, Green D, Moore MAS, Nachman RL and Rafii S (1997) Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 94:663-668.
265. Molino M, Bainton DF, Hoxie JA, Coughlin SR and Brass LF (1997a) Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation. J Biol Chem 272:6011-6017.
266. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A, Hoxie JA, Schechter N, Woolkalis M and Brass LF (1997b) Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272:4043-4049.
267. Molino M, Woolkalis MJ, Reavey-Cantwell J, Pratico D, Andrade-Gordon P, Barnathan ES and Brass LF (1997c) Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment. J Biol Chem 272:11133-11141.
268. Muramatsu I, Laniyonu A, Moore GJ and Hollenberg MD (1992) Vascular actions of thrombin receptor peptide. Can J Physiol Pharmacol 70:996-1003.
269. Nagao M, Yamauchi J, Kaziro Y and Itoh H (1998) Involvement of protein kinase C and Src family tyrosine kinase in G alpha(q/11)-induced activation of c-jun N-terminal kinase and p38 mitogen-activated protein kinase. J Biol Chem 273: 22892-22898.
270. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ and Coughlin SR (2000) Par3 is a cofactor for PAR4 activation by thrombin. Nature (Lond) 404:609-613.
271. Naldini A, Sower L, Bocci V, Meyers B and Carney DH (1998) Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation. J Cell Physiol 177:76-84.
272. Nanevicz T, Ishii M, Wang L, Chen M, Chen J, Turck CW, Cohen FE and Coughlin SR (1995) Mechanisms of thrombin receptor agonist specificity. Chimeric receptors and complementary mutations identify an agonist recognition site. J Biol Chem 270:21619-21625.
273. Nanevicz T, Wang L, Chen M, Ishii M and Coughlin SR (1996) Thrombin receptor activating mutations. Alteration of an extracellular agonist recognition domain causes constitutive signaling. J Biol Chem 271:702-706.
274. Napoli C, Cicala C, Wallace JL, de Nigris F, Santagada V, Caliendo C, Franconi F, Ignarro LJ and Cirino G (2000) Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. Proc Natl Acad Sci USA 97: 3678-3683.
275. Natarajan S, Riexinger D, Peluso M and Seiler SM (1995) Tethered ligand derived pentapeptide agonists of thrombin receptor - a study of side-chain requirements for human platelet activation and GTPase Stimulation. Int J Peptide Protein Res 45:145-151.
276. Negrescu EV, de Quintana KL and Siess W (1995) Platelet shape change induced by thrombin receptor activation. Rapid stimulation of tyrosine phosphorylation of novel protein substrates through an integrin- and Ca(2+)-independent mechanism. J Biol Chem 270:1057-1061.
277. Nelken NA, Soifer SJ, O'Keefe J, Vu TK, Charo IF and Coughlin SR (1992) Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 90:1614-1621.
278. Neveu I, Jehan F, Jandrotperrus M, Wion D and Brachet P (1993) Enhancement of the synthesis and secretion of nerve growth factor in primary cultures of glial cells by proteases - a possible involvement of thrombin. J Neurochem 60:858-867.
279. Nguyen M, Arkell J and Jackson CJ (1999a) Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism independent of active MT1 matrix metalloproteinase. Lab Invest 79:467-475.
280. Nguyen TD, Moody MW, Steinhoff M, Okolo C, Koh DS and Bunnett NW (1999b) Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest 103:261-269.
281. Nierodzik ML, Chen K, Takeshita K, Li JJ, Huang YQ, Feng XS, D'Andrea MR, Andrade-Gordon P and Karpatkin S (1998) Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 92:3694-3700.
282. Nierodzik ML, Klepfish A and Karpatkin S (1995) Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemostasis 74:282-290.
283. Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H and Yoshimoto T (1993) Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 10:167-179.
284. Nose T, Fujita T, Nakajima M, Inoue Y, Costa T and Shimohigashi Y (1998a) Interaction mode of the phe-phenyl group of thrombin receptor-tethered ligand SFLLRNP in receptor activation. J Biochem 124:354-358.
285. Nose T, Satoh Y, Fujita T, Ohno M, Nakajima M, Inoue Y, Ogino Y, Costa T and Shimohigashi Y (1998b) The role of arginine in thrombin receptor tethered-ligand peptide in intramolecular receptor binding and self-activation. Bull Chem Soc Jpn 71:1661-1665.
286. Nose T, Shimohigashi Y, Ohno M, Costa T, Shimizu N and Ogino Y (1993) Enhancement of thrombin receptor activation by thrombin receptor-derived heptapeptide with para-fluorophenylalanine in place of phenylalanine. Biochem Biophys Res Commun 193:694-699.
287. Nystedt S, Emilsson K, Larsson AK, Strombeck B and Sundelin J (1995a) Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem 232:84-89.
288. Nystedt S, Emilsson K, Wahlestedt C and Sundelin J (1994) Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91:9208-9212.
289. Nystedt S, Larsson AK, Aberg H and Sundelin J (1995b) The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression. J Biol Chem 270:5950-5955.
290. Nystedt S, Ramakrishnan V and Sundelin J (1996) The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells -comparison with the thrombin receptor. J Biol Chem 271:14910-14915.
291. O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS and Brass LF (2000) Thrombin responses in human endothelial cells - contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 275:13502-13509.
292. Offermanns S, Laugwitz KL, Spicher K and Schultz G (1994) G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 91:504-508.
293. Offermanns S, Toombs CF, Hu YH and Simon MI (1997) Defective platelet activation in G alpha(q)-deficient mice. Nature (Lond) 389:183-186.
294. Ogino Y, Tanaka K and Shimizu N (1996) Direct evidence for two distinct G proteins coupling with thrombin receptors in human neuroblastoma SH-EP cells. Eur J Pharmacol 316:105-109.
295. Ohmori T, Yatomi Y, Asazuma N, Satoh K and Ozaki Y (2000) Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alpha lib beta 3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2. Biochem J 347:561-569.
296. Okamura T, Hasitz M and Jamieson GA (1978) Platelet glycocalicin: interaction with thrombin and role as thrombin receptor on the platelet surface. J Biol Chem 253:3435-3443.
297. Overton MC and Blumer KJ (2000) G-protein-coupled receptors function as oligomers in vivo. Curr Biol 10:341-344.
298. Pages G, Lenormand P, L'Allemain G, Chambard JC, Meloche S and Pouyssegur J (1993) Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 90:8319-8323.
299. Pendurthi UR, Allen KE, Ezban M and Rao LVM (2000) Factor Viia and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa center dot tissue factor-induced signal transduction. J Biol Chem 275:14632-14641.
300. Petersen LC, Thastrup O, Hagel G, Sorensen BB, Freskgard PO, Rao L VM and Ezban M (2000) Exclusion of known protease activated receptors in factor VIIa-induced signal transduction. Thromb Haemostasis 83:571-576.
301. Pike CJ, Vaughan PJ, Cunningham DD and Cotman CW (1996) Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by beta-amyloid in vitro. J Neurochem 66:1374-1382.
302. Pinheiro JMB, Andersen TT and Malik AB (1993) Receptor mechanism of thrombin-mediated pulmonary vasodilation in neonates. Am J Physiol 265:L355-L359.
303. Plantier JL, Berthier R, Rival Y, Schweitzer A and Rabiet MJ (1994) Evidence for a selective inhibitory effect of thrombin on megakaryocyte progenitor growth mediated by the thrombin receptor. Br J Haematol 87:755-762.
304. Post GR, Collins LR, Kennedy ED, Moskowitz SA, Aragay AM, Goldstein D and Brown JH (1996) Coupling of the thrombin receptor to G12 may account for selective effects of thrombin on gene expression and DNA synthesis in 1321N1 astrocytoma cells. Mol Biol Cell 7:1679-1690.
305. Rabiet MJP, Plantier JL, Rival Y, Genoux Y, Lampugnani MG and Dejana E (1996) Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol 16:488-496.
306. Ragosta M, Barry WL, Gimple LW, Gertz SD, McCoy KW, Stouffer GA, McNamara CA, Powers ER, Owens GK and Sarembock IJ (1996) Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits. Circulation 93:1194-1200.
307. Rao GN, Delafontaine P and Runge MS (1995) Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-gamma 1 in rat aortic smooth muscle cells. J Biol Chem 270:27871-27875.
308. Rasmussen UB, Vouret-Craviari V, Jallat S, Schlesinger Y, Pages G, Pavirani A, Lecocq JP, Pouyssegur J and Van Obberghen-Schilling E (1991) cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett 288:123-128.
309. Ricciardolo FLM, Steinhoff M, Amadesi S, Guerrini R, Tognetto M, Trevisani M, Creminon C, Bertrand C, Bunnett NW, Fabbri LM, Salvadori S and Geppetti P (2000) Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways. Am J Respir Crit Care Med 161:1672-1680.
310. Rivard N, McKenzie FR, Brondello JM and Pouyssegur J (1995) The phosphotyrosine phosphatase Ptp1d, but not Ptp1c, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G-protein-coupled receptors. J Biol Chem 270:11017-11024.
311. Rodriguez-Linares B and Watson SP (1994) Phosphorylation of JAK2 in thrombin-stimulated human platelets. FEBS Lett 352:335-338.
312. Roy SS, Saifeddine M, Loutzenhiser R, Triggle CR and Hollenberg MD (1998) Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity. Br J Pharmacol 123: 1434-1440.
313. Sabo T, Gurwitz D, Motola L, Brodt P, Barak R and Elhanaty E (1992) Structure-activity studies of the thrombin receptor activating peptide. Biochem Biophys Res Commun 188:604-610.
314. Sabri A, Muske G, Zhang HL, Pak E, Darrow A, Andrade-Gordon P and Steinberg SF (2000) Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors. Circ Res 86:1054-1061.
315. Saifeddine M, Al-Ani B, Cheng CH, Wang L and Hollenberg MD (1996) Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol 118:521-530.
316. Saifeddine M, Al-Ani B, Sandhu S, Wijesuriya SJ and Hollenberg MD (2001) Contractile actions of proteinase-activated receptor-derived polypeptides in guinea-pig gastric and lung parenchymal strips: evidence for distinct receptor systems. Br J Pharmacol 132:556-566.
317. Saifeddine M, Roy SS, Al-Ani B, Triggle CR and Hollenberg MD (1998) Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor. Br J Pharmacol 125:1445-1454.
318. Sakaguchi K, Kodama H, Ogino Y, Costa T, Nose T and Shimohigashi Y (1994) Structural essentials of Ser-1 in tethered peptide ligand of human thrombin receptor for phosphoinositide hydrolysis. Bull Chem Soc Jpn 67:1659-1663.
319. Salahpour A, Angers S and Bouvier M (2000) Functional significance of oligomerization of G-protein-coupled receptors. Trends Endocrinol Metab 11:163-168.
320. Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C and Coughlin SR (2000) Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 275:6819-6823.
321. Santos J, Saperas E, Nogueiras C, Mourelle M, Antolin M, Cadahia A and Malagelada JR (1998) Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology 114:640-648.
322. Santulli RJ, Derian CK, Darrow AL, Tomko KA, Eckardt AJ, Seiberg M, Scarborough RM and Andrade-Gordon P (1995) Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proc Natl Acad Sci USA 92:9151-9155.
323. Satoh K, Ozaki Y, Asazuma N, Yatomi Y, Qi RM, Kuroda K, Yang LB and Kume S (1996) Differential mobilization of tyrosine kinases in human platelets stimulated with thrombin or thrombin receptor agonist peptide. Biochem Biophys Res Commun 225:1084-1089.
324. Sawada K, Nishibori M, Nakaya N, Wang Z and Saeki K (2000) Purification and characterization of a trypsin-like serine proteinase from rat brain slices that degrades laminin and type IV collagen and stimulates protease-activated receptor-2. J Neurochem 74:1731-1738.
325. Scarborough RM, Naughton MA, Teng W, Hung DT, Rose J, Vu TK, Wheaton VI, Turck CW and Coughlin SR (1992a) Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem 267:13146-13149.
326. Scarborough RM, Teng W, Naughton MA, Rose JW, Alves V and Arfsten A (1992b) A thrombin receptor antagonist designed from tethered ligand agonist peptides. Circulation 86:151-151.
327. Schechter NM, Brass LF, Lavker RM and Jensen PJ (1998) Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J Cell Physiol 176:365-373.
328. Schmidt VA, Nierman WC, Maglott DR, Cupit LD, Moskowitz KA, Wainer JA and Bahou WF (1998) The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a Par gene cluster and characterization in vascular endothelial cells and platelets. J Biol Chem 273:15061-15068.
329. Schultheiss M, Neumcke B and Richter HP (1997) Endogenous trypsin receptors in Xenopus oocytes: linkage to internal calcium stores. Cell Mol Life Sci 53:842-849.
330. Schwartz LB (1994) Tryptase: a mast cell serine protease. Methods Enzymol 244: 88-100.
331. Seasholtz TM, Majumdar M, Kaplan DD and Brown JH (1999) Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. Circ Res 84:1186-1193.
332. Seiberg M, Paine C, Sharlow E, Andrade-Gordon P, Costanzo M, Eisinger M and Shapiro SS (2000a) The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res 254:25-32.
333. Seiberg M, Paine C, Sharlow E, Andrade-Gordon P, Costanzo M, Eisinger M and Shapiro SS (2000b) Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol 115:162-167.
334. Seiberg M, Siock P, Wisniewski S, Cauwenbergh G and Shapiro SS (1997a) The effects of trypsin on apoptosis, utriculi size, and skin elasticity in the Rhino mouse. J Invest Dermatol 109:370-376.
335. Seiberg M, Wisniewski S, Cauwenbergh G and Shapiro SS (1997b) Trypsin-induced follicular papilla apoptosis results in delayed hair growth and pigmentation. Dev Dyn 208:553-564.
336. Seiler SM, Peluso M, Michel IM, Goldenberg H, Fenton JW, Riexinger D and Natarajan S (1995) Inhibition of thrombin and SFLLR-peptide stimulation of platelet-aggregation, phospholipase a(2) and Na+/H+ exchange by a thrombin receptor antagonist. Biochem Pharmacol 49:519-528.
337. Seiler SM, Peluso M, Tuttle JG, Pryor K, Klimas C, Matsueda GR and Bernatowicz MS (1996) Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists. Mol Pharmacol 49:190-197.
338. Seuwen K, Kahan C, Hartmann T and Pouyssegur J (1990) Strong and persistent activation of inositol lipid breakdown induces early mitogenic events but not GO to S phase progression in hamster fibroblasts - comparison of thrombin and carbachol action in cells expressing M1 muscarinic acetylcholine-receptors. J Biol Chem 265:22292-22299.
339. Shapiro MJ and Coughlin SR (1998) Separate signals for agonist-independent and agonist-triggered trafficking of protease-activated receptor 1. J Biol Chem 273: 29009-29014.
340. Shapiro MJ, Trejo J, Zeng D and Coughlin SR (1996) Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization. J Biol Chem 271:32874-32880.
341. Shapiro MJ, Weiss EJ, Faruqi TR and Coughlin SR (2000) Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem 275:25216-25221.
342. Sharlow ER, Paine CS, Babiarz L, Eisinger M, Shapiro S and Seiberg M (2000) The protease-activated receptor-2 upregulates keratinocyte phagocytosis. J Cell Sci 113:3093-3101.
343. Shimamoto T, Tsuboi H, Kitajima Y, Miyazaki T, Oyama Y, Imajo S and Ishiguro M (1995) Modified thrombin receptor-agonist peptide ligands - synthesis and conformational-analysis of analogs of the N-terminal tripeptide region. Bioorg Med Chem Lett 5:2417-2422.
344. Shimohigashi Y, Nose T, Okazaki M, Satoh Y, Ohno M, Costa T, Shimizu N and Ogino Y (1994) Differential roles of 2 consecutive phenylalanine residues in thrombin receptor-tethered ligand peptides (SFFLRNP) in thrombin receptor activation. Biochem Biophys Res Commun 203:366-372.
345. Shuman MA (1986) Thrombin-cellular interactions. Ann N Y Acad Sci 485:228-239.
346. Sinha U, Ku P, Malinowski J, Zhu BY, Scarborough RM, Marlowe CK, Wong PW, Lin PH and Hollenbach SJ (2000) Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis. Eur J Pharmacol 395:51-59.
347. Smith R, Jenkins A, Lourbakos A, Thompson P, Ramakrishnan V, Tomlinson J, Deshpande U, Johnson DA, Jones R, Mackie EJ and Pike RN (2000) Evidence for the activation of PAR-2 by the sperm protease, acrosin: expression of the receptor on oocytes. FEBS Lett 484:285-290.
348. Smith-Swintosky VL, Cheo-Isaacs CT, D'Andrea MR, Santulli RJ, Darrow AL and Andrade-Gordon P (1997) Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration. J Neurochem 69: 1890-1896.
349. Smith-Swintosky VL, Zimmer S, Fenton JW and Mattson MP (1995) Opposing actions of thrombin and protease nexin-1 on amyloid beta-peptide toxicity and on accumulation of peroxides and calcium in hippocampal neurons. J Neurochem 65:1415-1418.
350. Sobey CG and Cocks TM (1998) Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo. Stroke 29: 1439-1444.
351. Sobey CG, Moffatt JD and Cocks TM (1999) Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation. Stroke 30:1933-1940.
352. Steinberg SF, Robinson RB, Lieberman HB, Stern DM and Rosen MR (1991) Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. Circ Res 68:1216-1229.
353. Steinhoff M, Corvera CU, Thoma MS, Kong W, Caughey GH, Ansel JC and Bunnett NW (1999) Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8:282-294.
354. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, Trevisani M, Hollenberg MD, Wallace JL, Caughey GH, Mitchell SE, Williams LM, Geppetti P, Mayer EA and Bunnett NW (2000) Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nature Med 6:151-158.
355. Stenberg PE, McEver RP, Shuman MA, Jacques YV and Bainton DF (1985) A platelet alpha-granule membrane-protein (Gmp-140) is expressed on the plasma-membrane after activation. J Cell Biol 101:880-886.
356. Storck J, Kusters B, Vahland M, MorysWortmann C and Zimmermann ER (1996) Trypsin induced von Willebrand factor release from human endothelial cells is mediated by PAR-2 activation. Thromb Res 84:463-473.
357. Storck J, Vahland M, Breer T and Zimmermann ER (1997) Brefeldin A inhibits thrombin receptor regeneration in human endothelial cells. Br J Haematol 99: 555-561.
358. Storck J and Zimmermann ER (1996) Regulation of the thrombin receptor response in human endothelial cells. Thromb Res 81:121-131.
359. Striggow F, Riek M, Breder J, Henrich-Noack P, Reymann KG and Reiser G (2000) The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci USA 97:2264-2269.
360. Stubbs MT and Bode W (1993) A player of many parts-the spotlight falls on thrombins structure. Thromb Res 69:1-58.
361. Sugama Y and Malik AB (1992) Thrombin receptor-14 amino-acid peptide mediates Endothelial hyperadhesivity and neutrophil adhesion by P-selectin dependent mechanism. Circ Res 71:1015-1019.
362. Suidan HS, Niclou SP and Monard D (1996) The thrombin receptor in the nervous system. Semin Thromb Hemostasis 22:125-133.
363. Suzuki A, Kozawa O, Shinoda J, Watanabe Y, Saito H and Oiso Y (1996) Thrombin induces proliferation of osteoblast-like cells through phosphatidylcholine hydrolysis. J Cell Physiol 168:209-216
364. Swift S, Sheridan PJ, Covic L and Kuliopulos A (2000) Pari thrombin receptor-G protein interactions - separation of binding and coupling determinants in the G alpha subunit. J Biol Chem 275:2627-2635.
365. Takada M, Ito O, Kogushi M, Kobayashi H, Yamada T, Tanaka H, Yoshitake S and Saito I (1995) Binding of biotinylated thrombin receptor peptide to cloned human thrombin receptor overexpressed in baby hamster kidney cells. J Recept Signal Transduct Res 15:103-115.
366. Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR and Craik CS (2000) Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 275:26333-26342.
367. Tam SW, Fenton JW II and Detwiler TC (1980) Platelet thrombin receptors-binding of alpha-thrombin is coupled to signal generation by a chymotrypsin-sensitive mechanism. J Biol Chem 255:6626-6632.
368. Tanaka H, Suva LJ, Duong LT and Rodan GA (1993) Cloning of the mouse thrombin receptor from osteoblastic cells and regulation of its expression by 1,25-dihydroxyvitamin-D(3) and parathyroid-hormone. J Bone Miner Res 8:S143.
369. Tay-Uyboco J, Poon MC, Ahmad S and Hollenberg MD (1995) Contractile actions of thrombin receptor-derived polypeptides in human umbilical and placental vasculature: evidence for distinct receptor systems. Br J Pharmacol 115:569-578.
370. Tesfamariam B (1994a) Distinct receptors and signaling pathways in alpha-thrombin-receptor and thrombin-receptor peptide-induced vascular contractions. Circ Res 74:930-936.
371. Tesfamariam B (1994b) Thrombin receptor-mediated vascular relaxation differentiated by a receptor antagonist and desensitization. Am J Physiol-Heart Circ Physiol 36:H1962-H1967.
372. Tiruppathi C, Yan W, Sandoval R, Naqvi T, Pronin AN, Benovic JL and Malik AB (2000) G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells. Proc Natl Acad Sci USA 97:7440-7445.
373. Tognetto M, Trevisani M, Maggiore B, Navarra G, Turini A, Geurrini R, Bunnet NW, Geppetti P and Harrison S (2000) Evidence that Par-1 and Par-2 mediate prostanoid-dependent contraction in isolated guinea-pig gallbladder. Br J Pharmacol 131:689-694
374. Toruniowa B and Jablonska S (1988) Mast-cells in the initial-stages of psoriasis. Arch Dermatol Res 280:189-193.
375. Touhara K, Hawes BE, Vanbiesen T and Lefkowitz RJ (1995) G-protein beta-gamma-subunits stimulate phosphorylation of SHC adapter protein. Proc Natl Acad Sci USA 92:9284-9287.
376. Trejo J and Coughlin SR (1999) The cytoplasmic tails of protease-activated receptor-1 and substance P receptor specify sorting to lysosomes versus recycling. J Biol Chem 274:2216-2224.
377. Trejo J, Hammes SR and Coughlin SR (1998) Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. Proc Natl Acad Sci USA 95:13698-13702.
378. Tsopanoglou NE, Pipilisynetos E and Maragoudakis ME (1993) Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am J Physiol 264:C1302-C1307.
379. 2+](i)-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Neuroscience 86:597-609.
380. Umarova BA, Dugina TN, Shestakova EV, Gluza E and Strukova SM (2000) Activation of rat mast cells upon stimulation of protease-activated receptor (PAR-1). Bull Exp Biol Med 129:370-373.
381. Van Corven EJ, Hordijk PL, Medema RH, Bos JL and Moolenaar WH (1993) Pertussis toxin-sensitive activation of P21(Ras) by G-protein-coupled receptor agonists in fibroblasts. Proc Natl Acad Sci USA 90:1257-1261.
382. Van Den Berghe H, Cassiman J-J, David G, Fryns J-P, Michaux J-L and Sokal G (1974) Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature (Lond) 251:437-438.
383. Van Obberghen-Schilling E, Rasmussen UB, Vouret-Craviari V, Lentes KU, Pavirani A and Pouyssegur J (1993) Structure-activity analysis of synthetic alpha-thrombin-receptor-activating peptides. Biochem J 292:667-671.
384. Vassallo RR Jr, Kieber-Emmons T, Cichowski K and Brass LF (1992) Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem 267:6081-6085.
385. Vaughan PJ, Pike CJ, Cotman CW and Cunningham DD (1995) Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci 15:5389-5401.
386. Vaughan PJ, Su J, Cotman CW and Cunningham DD (1994) Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimers disease. Brain Res 668:160-170.
387. Vemuri GS, Zhang J, Huang R, Keen JH and Rittenhouse SE (1996) Thrombin stimulates wortmannin-inhibitable phosphoinositide 3-kinase and membrane blebbing in CHRF-288 cells. Biochem J 314:805-810.
388. Vergnolle N (1999) Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J Immunol 163:5064-5069.
389. Vergnolle N (2000) Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology. Aliment Pharmacol Ther 14:257-266.
390. Vergnolle N, Hollenberg MD and Wallace JL (2000) Injection of proteinase-activated receptor-2-activating peptides (PAR2-APs) in the rat hindpaw induces hyperalgesia. FASEB J 14:A386.
391. Vergnolle N, MacNaughton WK, Al-Ani B, Saifeddine M, Wallace JL and Hollenberg MD (1998) Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci USA 95:7766-7771.
392. Vergnolle N, Wallace JL, Bunnett NW and Hollenberg MD (2001) Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 22:146-152.
393. Vergnolle N, Wallace JL and Hollenberg MD (1999) Activation of proteinase-activated receptor-2 (PAR-2) induces leukocyte adhesion. FASEB J 13:A668.
394. Vittet D, Mathieu MN, Launay JM and Chevillard C (1992) Thrombin inhibits proliferation of the human megakaryoblastic MEG-01 cell line: a possible involvement of a cyclic-AMP dependent mechanism. J Cell Physiol 150:65-75.
395. Vouret-Craviari V, Auberger P, Pouyssegur J and Van Obberghen-Schilling E (1995) Distinct mechanisms regulate 5-HT2 and thrombin receptor desensitization. J Biol Chem 270:4813-4821.
396. Vouret-Craviari V, Boquet P, Pouyssegur J and Van Obberghen-Schilling E (1998) Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol Biol Cell 9:2639-2653.
397. Vouret-Craviari V, Van Obberghen-Schilling E, Rasmussen UB, Pavirani A, Lecocq JP and Pouyssegur J (1992) Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol Biol Cell 3:95-102.
398. Vu TK, Hung DT, Wheaton VI and Coughlin SR (1991a) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
399. Vu TK, Wheaton VI, Hung DT, Charo I and Coughlin SR (1991b) Domains specifying thrombin-receptor interaction. Nature (Lond) 353:674-677.
400. Wakita H, Furukawa F and Takigawa M (1997) Thrombin and trypsin induce granulocyte-macrophage colony-stimulating factor and interleukin-6 gene expression in cultured normal human keratinocytes. Proc Assoc Am Phys 109:190-207.
401. Walker TR, Moore SM, Lawson MF, Panettieri RA Jr and Chilvers ER (1998) Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation. Mol Pharmacol 54:1007-1015.
402. Wallrapp C, Hahnel S, Muller Pillasch F, Burghardt B, Iwamura T, Ruthenburger M, Lerch MM, Adler G and Gress TM (2000) A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res 60:2602-2606.
403. Wang YF, Tsirka SE, Strickland S, Steig PE, Soriano SG and Lipton SA (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia ij wild-type and tPA deficient mice. Nature Med 4:228-231.
404. Watts IS, Keery RJ and Lumley P (1989) Differential ability of agonists to express distinct pools of fibrinogen (Gpiib/Iiia) receptors which can mediate the aggregation of human platelets. Thromb Haemostasis 62:955-961.
405. Weinstein JR, Gold SJ, Cunningham DD and Gall CM (1995) Cellular-localization of thrombin receptor messenger-RNA in rat-brain - expression by mesencephalic dopaminergic-neurons and codistribution with prothrombin messenger-RNA. J Neurosci 15:2906-2919.
406. Weinstein JR, Lau AL, Brass LF and Cunningham DD (1998) Injury-related factors and conditions down-regulate the thrombin receptor (PAR-1) in a human neuronal cell line. J Neurochem 71:1034-1050.
407. Weiss RH and Maduri M (1993) The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J Biol Chem 268:5724-5727.
408. Wilcox JN, Rodriguez J, Subramanian R, Ollerenshaw J, Zhong C, Hayzer DJ, Horaist C, Hanson SR, Lumsden A, Salam TA, Kelly AB, Harker LA and Runge M (1994) Characterization of thrombin receptor expression during vascular lesion formation. Circ Res 75:1029-1038.
409. Willmore LJ (1990) Post-traumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia 31:S67-S73.
410. 2+ and mitogen-activated protein kinase regulation. J Biol Chem 269:1889-1895.
411. Wojtukiewicz MZ, Tang DG, Benjosef E, Renaud C, Walz DA and Honn KV (1995) Solid tumor-cells express functional tethered ligand thrombin receptor. Cancer Res 55:698-704.
412. Wojtukiewicz MZ, Tang DG, Ciarelli JJ, Nelson KK, Walz DA, Diglio CA, Mammen EF and Honn KV (1993) Thrombin increases the metastatic potential of tumor-cells. Int J Cancer 54:793-806.
413. Woolkalis MJ, DeMelfi TM Jr, Blanchard N, Hoxie JA and Brass LF (1995) Regulation of thrombin receptors on human umbilical vein endothelial cells. J Biol Chem 270:9868-9875.
414. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW and Foster DC (1998) Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 95:6642-6646.
415. Xu YC, Zacharias U, Peraldi MN, He CJ, Lu CY, Sraer JD, Brass LF and Rondeau E (1995) Constitutive expression and modulation of the functional thrombin receptor in the human kidney. Am J Pathol 146:101-110.
416. Yahagi N, Ichinose M, Matsushima M, Matsubara Y, Miki K, Kurokawa K, Fukamachi H, Tashiro K, Shiokawa K, Kageyama T, Takahashi T, Inoue H and Takahashi K (1996) Complementary DNA cloning and sequencing of rat enteropeptidase and tissue distribution of its mRNA. Biochem Biophys Res Commun 219:806-812.
417. Yamabe H, Osawa H, Inuma H, Kaizuka M, Tamura N, Tsunoda S, Baba Y, Shirato K and Onodera K (1997) Thrombin stimulates production of transforming growth factor-beta by cultured human mesangial cells. Nephrol Dialysis Transplant 12: 438-442.
418. Yamaoka K, Masuda K, Ogawa H, Takagi K, Umemoto N and Yasuoka S (1901) (1998) Cloning and characterization of the cDNA for human airway trypsin-like protease. J Biol Chem 273:11895-11901.
419. Yamashiro K, Tsuruoka N, Kodama S, Tsujimoto M, Yamamura Y, Tanaka T, Nakazato H and Yamaguchi N (1997) Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim Biophys Acta Gene Struct Express 1350:11-14.
420. Yan W, Tiruppathi C, Lum H, Qiao R and Malik AB (1998) Protein kinase C beta regulates heterologous desensitization of thrombin receptor (PAR-1) in endothelial cells. Am J Physiol 274:0387-396.
421. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K and Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond) 332:411-415.
422. Yang SG, Laniyonu A, Saifeddine M, Moore GJ and Hollenberg MD (1992) Actions of thrombin and thrombin receptor peptide analogs in gastric and aortic smooth-muscle development of bioassays for structure-activity studies. Life Sci 51:1325-1332.
423. Yu Z, Ahmad S, Schwartz JL, Banville D and Shen SH (1997) Protein-tyrosine phosphatase SHP2 is positively linked to proteinase-activated receptor 2-mediated mitogenic pathway. J Biol Chem 272:7519-7524.
424. Zacharski LR, Memoli VA, Morain WD, Schlaeppi JM and Rousseau SM (1995) Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding. Thromb Haemostasis 73:793-797.
425. Zaleski JK and Ku DD (1993) Receptor mechanism of thrombin-induced endothelium-dependent and endothelium-independent coronary vascular effects in dogs. FASEB Jl 7:A118.
426. Zeng FY and Wess J (2000) Molecular aspects of muscarinic receptor dimerization. Neuropsychopharmacology 23:S19-S31.
427. Zhang J, Benovic JL, Sugai M, Wetzker R, Gout I and Rittenhouse SE (1995) Sequestration of a G-protein beta gamma subunit or ADP-ribosylation of Rho can inhibit thrombin-induced activation of platelet phosphoinositide 3-kinases. J Biol Chem 270:6589-6594.
428. Zhong C, Hayzer DJ, Corson MA and Runge MS (1992) Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vitro regulation by basic fibroblast growth factor. J Biol Chem 267:16975-16979.
429. Zimmerman BJ, Paulson JC, Arrhenius TS, Gaeta FCA and Granger DN (1994) Thrombin receptor peptide-mediated leukocyte rolling in rat mesenteric venules -roles of P-selectin and sialyl-Lewis. X. Am J Physiol 267:H1049-H1053.
430. Zucker S, Conner C, DiMassmo BI, Ende H, Drews M, Seiki M and Bahou WF (1995) Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis. J Biol Chem 270:23730-23738.